Literature DB >> 32251703

Association of miR-760 with cancer: An overview.

Monika Kaushik Siddharth Manvati1, Juveria Khan1, Neeraj Verma1, Pawan K Dhar2.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNA molecules of around 22 nucleotides in length. They are crucially involved in the post transcriptional regulation and thus play a significant role in the modulation of different diseases. Several studies have suggested that miRNA expression is dysregulated in various cancers through different mechanisms and the dysregulated miRNA in return affects different cancer hallmarks including cell proliferation, cell death suppression, metastasis and angiogenesis. Compilation of the available miRNA data can be a stimulator for proper understanding of the correlation between the miRNA expression and cancer progression. In this review, we have focussed on the role of miR-760 in the progression of different cancer. MicroRNA-760 (miR-760) has been found to be down regulated in various cancers, thus it can be utilized as a possible prognostic marker for cancer detection. Here, we have tried to fill a gap regarding the role of miR-760 in relation to cervical cancer also. Moreover, unravelling the role of miR-760 in different cancers will enlighten the researchers with proper understanding of biology of miR-760 in regulation of different cancers.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Non-coding DNA; Regulation; miR-760; micro RNA; microRNA targets

Mesh:

Substances:

Year:  2020        PMID: 32251703     DOI: 10.1016/j.gene.2020.144648

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661/RAB3D.

Authors:  Xing Lin; Liang Zhong; Nian Wang; Xuan Chu; Beizhong Liu
Journal:  Cell Cycle       Date:  2022-05-13       Impact factor: 5.173

2.  Long Non-Coding RNA UBA6-AS1 Promotes the Malignant Properties of Glioblastoma by Competitively Binding to microRNA-760 and Enhancing Homeobox A2 Expression.

Authors:  Feifei Cheng; Jiang Liu; Yundong Zhang; Qiuxiang You; Bo Chen; Jing Cheng; Chunyan Deng
Journal:  Cancer Manag Res       Date:  2021-01-14       Impact factor: 3.989

3.  The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis.

Authors:  Xinwei Huang; Huazheng Liang; Hong Zhang; Li Tian; Peilin Cong; Tingmei Wu; Qian Zhang; Xiaofei Gao; Wanrong Li; Aiwen Chen; Yuxin Zhang; Qianyu Dong; Hanxi Wan; Mengfan He; Danqing Dai; Zhen Li; Lize Xiong
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

4.  Microarray Identifies a Key Carcinogenic Circular RNA 0008594 That Is Related to Non-Small-Cell Lung Cancer Development and Lymph Node Metastasis and Promotes NSCLC Progression by Regulating the miR-760-Mediated PI3K/AKT and MEK/ERK Pathways.

Authors:  Qiushi Wang; Chunhua Yan; Pengfei Zhang; Guanghua Li; Ruidong Zhu; Hanbing Wang; Libo Wu; Guangquan Xu
Journal:  Front Oncol       Date:  2021-11-11       Impact factor: 6.244

Review 5.  Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View.

Authors:  Aigli Korfiati; Katerina Grafanaki; George C Kyriakopoulos; Ilias Skeparnias; Sophia Georgiou; George Sakellaropoulos; Constantinos Stathopoulos
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

6.  microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1.

Authors:  Kexin Jiang; Huawei Zou
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

7.  lncRNA SLC9A3-AS1 Promotes Oncogenesis of NSCLC via Sponging microRNA-760 and May Serve as a Prognosis Predictor of NSCLC Patients.

Authors:  Xiuming Huang; Mingfang Huang; Minbiao Chen; Xianshan Chen
Journal:  Cancer Manag Res       Date:  2022-03-09       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.